TMED4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.79298806304951E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.19049999969256E-07 |
Normal-vs-Stage2 |
7.939900E-03 |
Normal-vs-Stage3 |
1.18739462706685E-11 |
Normal-vs-Stage4 |
7.61819995975799E-09 |
Stage1-vs-Stage2 |
9.933800E-01 |
Stage1-vs-Stage3 |
6.605500E-04 |
Stage1-vs-Stage4 |
6.263200E-03 |
Stage2-vs-Stage3 |
4.402300E-02 |
Stage2-vs-Stage4 |
6.072200E-02 |
Stage3-vs-Stage4 |
9.000000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.5679020262196E-12 |
Normal-vs-AfricanAmerican |
3.25799999978393E-07 |
Normal-vs-Asian |
4.733600E-01 |
Caucasian-vs-AfricanAmerican |
3.317200E-01 |
Caucasian-vs-Asian |
3.913600E-01 |
AfricanAmerican-vs-Asian |
2.024800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.45163914011937E-12 |
Normal-vs-Female |
3.37579999509785E-08 |
Male-vs-Female |
3.350800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.052000E-02 |
Normal-vs-Age(41-60Yrs) |
3.56389999733864E-08 |
Normal-vs-Age(61-80Yrs) |
8.37341307402539E-12 |
Normal-vs-Age(81-100Yrs) |
2.37489999999063E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.448600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.789000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.004000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.803200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.347370E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.015800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.688500E-02 |
Normal-vs-Grade 2 |
4.13109999986006E-07 |
Normal-vs-Grade 3 |
1.02730002282669E-09 |
Normal-vs-Grade 4 |
6.88338275267597E-15 |
Grade 1-vs-Grade 2 |
5.074600E-01 |
Grade 1-vs-Grade 3 |
2.559000E-01 |
Grade 1-vs-Grade 4 |
2.780200E-03 |
Grade 2-vs-Grade 3 |
9.978000E-02 |
Grade 2-vs-Grade 4 |
3.02390000039843E-07 |
Grade 3-vs-Grade 4 |
6.634900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.593110E-04 |
Normal-vs-ccB subtype |
2.60369947824302E-10 |
ccA subtype-vs-ccB subtype |
8.447500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.90649981649472E-10 |
Normal-vs-N1 |
1.542420E-02 |
N0-vs-N1 |
3.053400E-01 |
|
|